Table 1.
Correlations between serum miR-503 expression levels and clinical parameters
Variables | GC patients (n=68) |
Healthy controls (n=30) |
P-value |
---|---|---|---|
Age (years) | 0.237 | ||
<60 | 25 | 16 | |
≥60 | 43 | 14 | |
Sex | 0.205 | ||
Male | 43 | 20 | |
Female | 25 | 10 | |
Tumor size (cm) | 0.132 | ||
<5 | 40 | ||
≥5 | 28 | ||
Histological grade | 0.394 | ||
Well and moderate | 19 | ||
Poor and others | 49 | ||
Depth of tumor | 0.152 | ||
T1, T2 | 17 | ||
T3, T4 | 51 | ||
Lymphatic metastasis | 0.029* | ||
Absent | 27 | ||
Present | 41 | ||
Distant metastasis | 0.036 | ||
Absent | 52 | ||
Present | 16 | ||
Tumor stagea | 0.031* | ||
I and II | 24 | ||
III and IV | 44 |
Notes:
According to the TNM criteria.
P<0.05.
Abbreviation: GC, gastric cancer.